BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26503631)

  • 1. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
    Roy HK; Turzhitsky V; Wali R; Radosevich AJ; Jovanovic B; Della'Zanna G; Umar A; Rubin DT; Goldberg MJ; Bianchi L; De La Cruz M; Bogojevic A; Helenowski IB; Rodriguez L; Chatterton R; Skripkauskas S; Page K; Weber CR; Huang X; Richmond E; Bergan RC; Backman V
    Gut; 2017 Feb; 66(2):285-292. PubMed ID: 26503631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
    Wali RK; Bianchi L; Kupfer S; De La Cruz M; Jovanovic B; Weber C; Goldberg MJ; Rodriguez LM; Bergan R; Rubin D; Tull MB; Richmond E; Parker B; Khan S; Roy HK
    PLoS One; 2018; 13(4):e0193544. PubMed ID: 29617381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
    Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.
    Chow HH; Earnest DL; Clark D; Mason-Liddil N; Kramer CB; Einspahr JG; Guillen-Rodriguez JM; Roe DJ; Malone W; Crowell JA; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):351-6. PubMed ID: 10794478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial.
    Ishikawa H; Mutoh M; Suzuki S; Tokudome S; Saida Y; Abe T; Okamura S; Tajika M; Joh T; Tanaka S; Kudo SE; Matsuda T; Iimuro M; Yukawa T; Takayama T; Sato Y; Lee K; Kitamura S; Mizuno M; Sano Y; Gondo N; Sugimoto K; Kusunoki M; Goto C; Matsuura N; Sakai T; Wakabayashi K
    Gut; 2014 Nov; 63(11):1755-9. PubMed ID: 24488498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker.
    Sample D; Wargovich M; Fischer SM; Inamdar N; Schwartz P; Wang X; Do KA; Sinicrope FA
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):275-9. PubMed ID: 11895877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.
    Thomas SS; Makar KW; Li L; Zheng Y; Yang P; Levy L; Rudolph RY; Lampe PD; Yan M; Markowitz SD; Bigler J; Lampe JW; Potter JD
    BMC Med Genet; 2015 Mar; 16():18. PubMed ID: 25927723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Low-dose and Standard-dose Aspirin on PGE
    Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
    Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of tumor development in the colons of living rats and implications for chemoprevention trials: assessment of aspirin-difluoromethylornithine combination.
    Raul F; Gosse F; Osswald AB; Bouhadjar M; Foltzer-Jourdainne C; Marescaux J; Soler L
    Int J Oncol; 2007 Jul; 31(1):89-95. PubMed ID: 17549408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal Optical Markers for In Vivo Risk Stratification of Premalignant Colorectal Lesions.
    Radosevich AJ; Mutyal NN; Eshein A; Nguyen TQ; Gould B; Rogers JD; Goldberg MJ; Bianchi LK; Yen EF; Konda V; Rex DK; Van Dam J; Backman V; Roy HK
    Clin Cancer Res; 2015 Oct; 21(19):4347-4355. PubMed ID: 25991816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of colon carcinogenesis through enhanced backscattering spectroscopy analysis of the uninvolved colonic mucosa.
    Roy HK; Kim YL; Liu Y; Wali RK; Goldberg MJ; Turzhitsky V; Horwitz J; Backman V
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):961-8. PubMed ID: 16467111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
    Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
    Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
    Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
    Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
    J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.
    Ruffin MT; Krishnan K; Rock CL; Normolle D; Vaerten MA; Peters-Golden M; Crowell J; Kelloff G; Boland CR; Brenner DE
    J Natl Cancer Inst; 1997 Aug; 89(15):1152-60. PubMed ID: 9262254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS; McCloskey C; McSkimming P; McConnachie A
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.